T1	chemical 61 71	perampanel
T3	disease_or_phenotypic_feature 116 124	seizures
T4	disease_or_phenotypic_feature 150 156	glioma
T6	chemical 236 247	antagonists
T7	chemical 251 260	adenosine
T8	disease_or_phenotypic_feature 289 296	obesity
T9	chemical 310 319	adenosine
T10	disease_or_phenotypic_feature 372 379	obesity
T11	chemical 458 468	biological
T12	disease_or_phenotypic_feature 516 529	breast cancer
T13	chemical 531 540	Pazopanib
T15	disease_or_phenotypic_feature 583 588	wound
T16	disease_or_phenotypic_feature 667 671	pale
T17	chemical 767 777	inhibitors
T19	disease_or_phenotypic_feature 802 811	dependent
T20	chemical 923 927	drug
T21	disease_or_phenotypic_feature 938 946	seizures
T22	chemical 1051 1058	hormone
T23	chemical 1092 1096	ACTH
T24	disease_or_phenotypic_feature 1125 1143	Cushing's syndrome
T26	disease_or_phenotypic_feature 1300 1329	multiple chemical sensitivity
T27	chemical 1309 1317	chemical
T28	disease_or_phenotypic_feature 1330 1335	(MCS)
T29	chemical 1371 1385	Aminoguanidine
T30	chemical 1399 1408	inhibitor
T31	disease_or_phenotypic_feature 1444 1453	cataracts
T32	chemical 1494 1503	potassium
T33	chemical 1516 1522	sodium
T34	chemical 1526 1535	potassium
T35	disease_or_phenotypic_feature 1562 1569	obesity
T36	chemical 1571 1583	Temozolomide
T37	chemical 1591 1595	drug
T38	disease_or_phenotypic_feature 1627 1636	malignant
T39	chemical 1703 1707	drug
T40	chemical 1709 1720	sibutramine
T41	chemical 1728 1738	adrenaline
T42	chemical 1764 1773	inhibitor
T43	disease_or_phenotypic_feature 1817 1824	obesity
T44	chemical 1853 1859	leptin
T45	chemical 1860 1867	biology
T46	chemical 1898 1904	leptin
T47	disease_or_phenotypic_feature 1926 1933	obesity
T48	disease_or_phenotypic_feature 1945 1953	diabetes
T49	disease_or_phenotypic_feature 1958 1965	obesity
T51	disease_or_phenotypic_feature 2040 2057	cerebral ischemia
T52	chemical 2101 2107	oxygen
T53	disease_or_phenotypic_feature 2117 2123	Anemia
T54	chemical 2165 2171	oxygen
T55	disease_or_phenotypic_feature 2327 2330	AML
T56	chemical 2372 2380	antigens
T58	chemical 2507 2514	antigen
T59	chemical 2556 2566	biomarkers
T60	disease_or_phenotypic_feature 2599 2605	cancer
T61	chemical 2630 2641	biochemical
T62	disease_or_phenotypic_feature 2659 2667	seminoma
T63	chemical 2689 2692	sec
T64	chemical 2694 2697	sed
T66	chemical 2835 2845	inhibitors
T67	chemical 2850 2858	platinum
T68	disease_or_phenotypic_feature 2963 2980	pancreatic cancer
T69	missed_chemical 73 76	PER
T71	chemical 87 111	AMPA receptor antagonist
T2	disease_or_phenotypic_feature 129 134	tumor
#1	AnnotatorNotes T71	Compartment? 
R1	treats Arg1:T1 Arg2:T3	
R2	treats Arg1:T1 Arg2:T2	
R3	treats Arg1:T1 Arg2:T4	
R4	treats Arg1:T9 Arg2:T10	
T5	chemical 220 228	agonists
R5	treats Arg1:T7 Arg2:T8	
T70	missed_disease_or_phenotypic_feature 401 419	nsulin sensitivity
T72	missed_disease_or_phenotypic_feature 424 437	thermogenesis
T73	missed_disease_or_phenotypic_feature 389 398	lipolysis
T74	missed_disease_or_phenotypic_feature 452 457	tumor
T75	missed_disease_or_phenotypic_feature 480 485	tumor
T14	corrected_disease_or_phenotypic_feature 575 588	retinal wound
R6	causes_or_contributes_to Arg1:T13 Arg2:T14	
T76	missed_chemical 747 766	farnesyltransferase
T77	missed_disease_or_phenotypic_feature 844 852	epilepsy
T78	missed_disease_or_phenotypic_feature 864 870	tumors
T79	missed_chemical 994 997	FDG
T80	missed_disease_or_phenotypic_feature 1069 1075	tumors
T25	missed_chemical 1395 1398	NOS
R7	treats Arg1:T25 Arg2:T31	
R8	causes_or_contributes_to Arg1:T34 Arg2:T35	
R9	treats Arg1:T36 Arg2:T38	
R10	treats Arg1:T40 Arg2:T43	
T50	disease_or_phenotypic_feature 2184 2190	tumors
T57	disease_or_phenotypic_feature 2581 2586	tumor
T65	chemical 2830 2834	PARP
T81	missed_disease_or_phenotypic_feature 2893 2898	tumor
R11	treats Arg1:T67 Arg2:T81	
T82	DONE 2982 2986	DONE
T83	corrected_chemical 748 777	arnesyltransferase inhibitors
R12	treats Arg1:T83 Arg2:T19	
T84	corrected_disease_or_phenotypic_feature 798 818	ras-dependent tumors
T18	corrected_disease_or_phenotypic_feature 1092 1113	ACTH-producing tumors
T85	corrected_disease_or_phenotypic_feature 1627 1644	malignant gliomas
T86	missed_chemical 1743 1753	serotonine
T87	corrected_disease_or_phenotypic_feature 1958 1986	obesity-related hypertension
T88	corrected_disease_or_phenotypic_feature 1926 1953	obesity-associated diabetes
T89	missed_chemical 2004 2016	hemodilution
T90	missed_chemical 2699 2702	see
T91	missed_chemical 2704 2707	seg
T92	missed_chemical 2709 2712	seh
T93	missed_chemical 2714 2717	sei
T94	missed_chemical 2719 2722	sej
T95	missed_chemical 2728 2731	tst
R13	treats Arg1:T9 Arg2:T73	
R14	treats Arg1:T7 Arg2:T72	
R15	treats Arg1:T7 Arg2:T70	
T96	corrected_disease_or_phenotypic_feature 523 529	cancer
T97	corrected_chemical 2830 2845	PARP inhibitors
R16	treats Arg1:T97 Arg2:T81	
R17	treats Arg1:T97 Arg2:T68	
